Application Sponsors
| ANDA 202858 | INVAGEN PHARMS |  | 
Marketing Status
| Prescription | 001 | 
| Prescription | 002 | 
Application Products
| 001 | CAPSULE;ORAL | 15MG | 0 | PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE | 
| 002 | CAPSULE;ORAL | 30MG | 0 | PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE | 
FDA Submissions
| UNKNOWN;  | ORIG | 1 | AP | 2014-02-14 |   | 
Submissions Property Types
TE Codes
| 001 | Prescription | AA | 
| 002 | Prescription | AA | 
CDER Filings
INVAGEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202858
            [companyName] => INVAGEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"PHENTERMINE HYDROCHLORIDE","activeIngredients":"PHENTERMINE HYDROCHLORIDE","strength":"15MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PHENTERMINE HYDROCHLORIDE","activeIngredients":"PHENTERMINE HYDROCHLORIDE","strength":"30MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/14\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"05\/31\/2017","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2017-05-31
        )
)